Difference between revisions of "Gross cystic disease fluid protein-15"

From Libre Pathology
Jump to navigation Jump to search
m (mamma)
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Gross cystic disease fluid protein-15''', usually abbreviated '''GCDFP-15''' and sometimes '''GCDFP''', is an [[immunostain]] help used to identify [[breast carcinoma]].
'''Gross cystic disease fluid protein-15''', usually abbreviated '''GCDFP-15''' and sometimes '''GCDFP''', is an [[immunostain]] help used to identify [[breast carcinoma]].


It is much less sensitive than mammoglobin.<ref>{{Cite journal  | last1 = Bhargava | first1 = R. | last2 = Beriwal | first2 = S. | last3 = Dabbs | first3 = DJ. | title = Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. | journal = Am J Clin Pathol | volume = 127 | issue = 1 | pages = 103-13 | month = Jan | year = 2007 | doi = 10.1309/TDP92PQLDE2HLEET | PMID = 17145637 }}</ref>
It is also known as '''BRST-2'''.<ref name=pmid8693878>{{Cite journal  | last1 = Fiel | first1 = MI. | last2 = Cernaianu | first2 = G. | last3 = Burstein | first3 = DE. | last4 = Batheja | first4 = N. | title = Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. | journal = Acta Cytol | volume = 40 | issue = 4 | pages = 637-41 | month =  | year =  | doi =  | PMID = 8693878 }}</ref>
 
It is much less sensitive than mammaglobin.<ref>{{Cite journal  | last1 = Bhargava | first1 = R. | last2 = Beriwal | first2 = S. | last3 = Dabbs | first3 = DJ. | title = Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. | journal = Am J Clin Pathol | volume = 127 | issue = 1 | pages = 103-13 | month = Jan | year = 2007 | doi = 10.1309/TDP92PQLDE2HLEET | PMID = 17145637 }}</ref>


==Microscopic==
==Microscopic==

Latest revision as of 15:42, 28 September 2018

Gross cystic disease fluid protein-15, usually abbreviated GCDFP-15 and sometimes GCDFP, is an immunostain help used to identify breast carcinoma.

It is also known as BRST-2.[1]

It is much less sensitive than mammaglobin.[2]

Microscopic

Features:

  • Cytoplasmic staining.

Images

www:

See also

References

  1. Fiel, MI.; Cernaianu, G.; Burstein, DE.; Batheja, N.. "Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.". Acta Cytol 40 (4): 637-41. PMID 8693878.
  2. Bhargava, R.; Beriwal, S.; Dabbs, DJ. (Jan 2007). "Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.". Am J Clin Pathol 127 (1): 103-13. doi:10.1309/TDP92PQLDE2HLEET. PMID 17145637.